DNA-Testing Site 23andMe Fights for Survival
Three years after reaching unprecedented heights with a market valuation surpassing Apple’s, DNA-testing firm 23andMe now finds itself in a struggle to survive. Once celebrated for its innovation in consumer genetic testing and its high-profile clientele, 23andMe has seen its stock price plummet to just under $5, a mere fraction of its peak at $321….
